PUBLIC CONTRACT · 2019
Ajuste direto para a aquisição de T1585 - Trastuzumab [150 mg; pó p/ conc p/ sol p/ perf; frs], R147 - Rituximab [100 mg/ 10 ml; frs] e R148 - Rituximab [500 mg/ 50 ml; frs] doentes em tratamento
- Contract value
- €66,529.45
- Signed on
- 5 June 2019
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6058234PUBLISHED DESCRIPTION
AD-2019-59
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE FARMACÊUTICA QUIMICA, LDA. · Tax ID 500233810
Values and timeline
- Contract price
- €66,529.45
- Procedure base price
- €119,733.84
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 November 2019
- Award date
- 29 May 2019
- Signing date
- 5 June 2019
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4022007
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.